[
  {
    "ts": null,
    "headline": "Danaher Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "Danaher Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=9f7d238204e53aa5a8d72ef26a53b6b33419c666e3fc1b0a5c5c1a623d672e88",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761669360,
      "headline": "Danaher Corp. stock underperforms Tuesday when compared to competitors",
      "id": 137252279,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=9f7d238204e53aa5a8d72ef26a53b6b33419c666e3fc1b0a5c5c1a623d672e88"
    }
  },
  {
    "ts": null,
    "headline": "Some Investors May Be Willing To Look Past Danaher's (NYSE:DHR) Soft Earnings",
    "summary": "Danaher Corporation's ( NYSE:DHR ) stock was strong despite it releasing a soft earnings report last week. Our analysis...",
    "url": "https://finnhub.io/api/news?id=1a8632419b890f39a8b6ab17fbd3ef8ff5e07fc70d03a1f47d8b90cff5a130b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761652803,
      "headline": "Some Investors May Be Willing To Look Past Danaher's (NYSE:DHR) Soft Earnings",
      "id": 137237986,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation's ( NYSE:DHR ) stock was strong despite it releasing a soft earnings report last week. Our analysis...",
      "url": "https://finnhub.io/api/news?id=1a8632419b890f39a8b6ab17fbd3ef8ff5e07fc70d03a1f47d8b90cff5a130b9"
    }
  },
  {
    "ts": null,
    "headline": "5 Must-Read Analyst Questions From Danaher’s Q3 Earnings Call",
    "summary": "Danaher’s third quarter was marked by solid execution across its core businesses, with management citing bioprocessing momentum and a stronger-than-anticipated performance in respiratory diagnostics as key drivers. CEO Rainer Blair highlighted that demand for monoclonal antibody production remained robust, propelling bioprocessing growth, while Cepheid’s respiratory testing revenues benefited from customers ordering earlier than usual. Management also pointed to disciplined cost management and o",
    "url": "https://finnhub.io/api/news?id=79f83065757b072ef8539f79df9222e94e39f109abfee4d1e1e789f1786d6277",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761629640,
      "headline": "5 Must-Read Analyst Questions From Danaher’s Q3 Earnings Call",
      "id": 137235554,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher’s third quarter was marked by solid execution across its core businesses, with management citing bioprocessing momentum and a stronger-than-anticipated performance in respiratory diagnostics as key drivers. CEO Rainer Blair highlighted that demand for monoclonal antibody production remained robust, propelling bioprocessing growth, while Cepheid’s respiratory testing revenues benefited from customers ordering earlier than usual. Management also pointed to disciplined cost management and o",
      "url": "https://finnhub.io/api/news?id=79f83065757b072ef8539f79df9222e94e39f109abfee4d1e1e789f1786d6277"
    }
  }
]